How MedTech companies decide when to patent device innovation and when to rely on trade secret protection, balancing enforcement leverage, disclosure risk, and reverse engineering realities.
Speaker(s):
Eda Stark
Global IP Transactions & Litigation Managing Counsel
Olympus
Gabriel Olander
Associate GC, IP Strategy
Intuitive
Agenda Track No.:
Track 2
Session Type:
Break / Networking
Force Inline Description:
0